Following a visit and document inspection by the Ministry of Industry, Mines, and Trade, Parsian pharmaceutical company was granted permission in 2017 to produce and synthesize novel Active Pharmaceutical Ingredients (APIs), establishing its status as one of the advanced industries in Iran. It is worth mentioning that all production lines at Parsian are thoroughly inspected and comply with the Good Manufacturing Practice (GMP) principles for pharmaceutical products currently enforced in the Islamic Republic of Iran.